Neuroscience Ph.D. student Lindsay Cameron and other researchers at UC Davis are actively exploring drugs capable of restoring health in the brains of those with mood disorders. Some dark horse candidates are psychedelics like LSD, psilocybin and DMT.
An advocate for computational and quantitative biology, Professor Mark Goldman has been appointed to the Joel Keizer Endowed Chair in Theoretical and Computational Biology. The position honors the late Professor Joel Keizer, a pioneering UC Davis faculty member and theoretical biologist who spent 28 years on campus.
The UC Davis College of Biological Sciences named Professor W. Martin Usrey, a neurobiologist interested in the physiology of vision, to the Barbara A. Horwitz and John M. Horowitz Endowed Chair in Physiology.
As a cognitive neuroscientist, Professor Charan Ranganath studies memory and learning, exploring the intricacies of the mind. But outside of the lab, the UC Davis researcher trades the EEG cap for an electric guitar.
Hearing loss is a substantial problem for society. It’s the third most common physical condition after arthritis and heart disease and about 30 percent of adults between ages 65 and 74 and nearly half of people over 75 experience some difficulty hearing. It’s a social problem, one that can lead to isolation and depression.
As healthcare professionals, pharmaceutical companies, patients and families grapple with the opioid crisis, researchers are rushing to design safer opioids. Center for Neuroscience Associate Director Jennifer Whistler believes drug development is headed in the wrong direction when it comes to opioids. Her solution: design a better drug that mimics the body's natural pain reliever, endorphin.